health United States
Some Americans seek cheaper unregulated GLP-1 versions
Millions of Americans reportedly face barriers to affording GLP-1 medications, leading some patients to seek cheaper, unregulated alternatives.
1 sourcePBS NewsUpdated
Claims
Support what holds up. Dispute what doesn't.
Millions of Americans face significant barriers to affording GLP-1 medications.
“millions of Americans still face significant barriers in affording GLP-1s”
Some patients seek alternative versions of GLP-1 medications.
“many patients have found alternative, cheaper paths to get their hands on unregulated versions”
The alternative GLP-1 versions are cheaper than regulated versions.
“alternative, cheaper paths”